{"log_id": 4881686480362421263, "direction": 0, "words_result_num": 18, "words_result": [{"probability": {"variance": 1.4e-05, "average": 0.997546, "min": 0.984977}, "location": {"width": 822, "top": 227, "height": 41, "left": 213}, "words": "此外,曾有在免疫重建时发生自身免疫失调(例如格雷夫斯病、多肌炎和格林巴利综"}, {"probability": {"variance": 3e-05, "average": 0.997594, "min": 0.972236}, "location": {"width": 770, "top": 257, "height": 40, "left": 212}, "words": "合征)的报告,然而,发病的时间更多样化,也可能在开始治疗后数个月内发生"}, {"probability": {"variance": 1e-06, "average": 0.998412, "min": 0.99637}, "location": {"width": 159, "top": 309, "height": 27, "left": 212}, "words": "早期病毒学失败"}, {"probability": {"variance": 0.001235, "average": 0.962727, "min": 0.927581}, "location": {"width": 26, "top": 273, "height": 61, "left": 1145}, "words": "批件"}, {"probability": {"variance": 0.00091, "average": 0.992917, "min": 0.814256}, "location": {"width": 817, "top": 339, "height": 38, "left": 213}, "words": "HIV感染受试者中的临床试验证明,与包含两种核苷逆转录酶抑制剂和一种非核苷逆"}, {"probability": {"variance": 0.002538, "average": 0.985718, "min": 0.712672}, "location": {"width": 821, "top": 368, "height": 40, "left": 213}, "words": "转录酶抑制剂或一种HIV蛋白酶抑制剂的三联药物治疗方案相比,某些只包含三种核"}, {"probability": {"variance": 0.004742, "average": 0.986167, "min": 0.563959}, "location": {"width": 823, "top": 397, "height": 38, "left": 211}, "words": "苷类反转录酶抑制剂(NRTI)的药物治疗方案总体上效用性较弱。尤其应考虑到已有"}, {"probability": {"variance": 1.5e-05, "average": 0.998182, "min": 0.976324}, "location": {"width": 815, "top": 424, "height": 44, "left": 212}, "words": "早期病毒学失败和高耐药性的报告。因而应谨慎使用三联核苷治疗方案。对使用三联"}, {"probability": {"variance": 3e-06, "average": 0.998772, "min": 0.993905}, "location": {"width": 507, "top": 455, "height": 35, "left": 210}, "words": "核苷类方案治疗的患者,应仔细监测并考虑改进疗法"}, {"probability": {"variance": 7.2e-05, "average": 0.995064, "min": 0.969391}, "location": {"width": 238, "top": 532, "height": 29, "left": 208}, "words": "[孕妇及哺乳期妇女用药]"}, {"probability": {"variance": 6e-06, "average": 0.998103, "min": 0.991746}, "location": {"width": 183, "top": 583, "height": 29, "left": 209}, "words": "美国妊娠分级B类"}, {"probability": {"variance": 1e-06, "average": 0.999101, "min": 0.996544}, "location": {"width": 810, "top": 633, "height": 42, "left": 207}, "words": "在大鼠和家兔中进行了生殖研究,根据体表面积比较的剂量最高分别为人的14和19"}, {"probability": {"variance": 2.5e-05, "average": 0.997364, "min": 0.974604}, "location": {"width": 793, "top": 661, "height": 43, "left": 207}, "words": "倍,结果显示没有证据表明因为替诺福韦造成生育力受损害或对胚胎有伤害。然而"}, {"probability": {"variance": 2e-06, "average": 0.998889, "min": 0.993253}, "location": {"width": 816, "top": 690, "height": 41, "left": 205}, "words": "没有在妊娠妇女中进行过充分及有良好对照的研究。由于动物生殖研究并不是总能预"}, {"probability": {"variance": 6.4e-05, "average": 0.995618, "min": 0.959919}, "location": {"width": 770, "top": 719, "height": 41, "left": 205}, "words": "测人的反应,因此在妊娠期内不应使用富马酸替诺福韦二吡呋酯,除非十分需要"}, {"probability": {"variance": 0, "average": 0.886173, "min": 0.886173}, "location": {"width": 198, "top": 846, "height": 68, "left": 838}, "words": "人"}, {"probability": {"variance": 0, "average": 0.789627, "min": 0.789627}, "location": {"width": 44, "top": 1023, "height": 48, "left": 971}, "words": "药"}, {"probability": {"variance": 0, "average": 0.941656, "min": 0.941656}, "location": {"width": 70, "top": 1045, "height": 170, "left": 1009}, "words": "今"}], "language": 3}